Risk factors for pharmacotherapy for storage symptoms after transurethral resection of the prostate in patients with benign prostatic hyperplasia

Objectives Postoperative persistence of storage symptoms after transurethral resection of the prostate (TURP) is bothersome, and evidence of its cause is sparse. We sought to analyze risk factors for using antimuscarinics or beta‐3 agonists after TURP in benign prostatic hyperplasia (BPH) patients....

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Lower urinary tract symptoms 2022-09, Vol.14 (5), p.329-333
Hauptverfasser:	Tsai, Cheng‐Han, Fan, Yu‐Hua, Lin, Alex T. L., Huang, William J.
Format:	Artikel
Sprache:	eng
Schlagworte:	benign prostatic hyperplasia Drug therapy Genital diseases Hyperplasia intravesical prostatic protrusion postoperative pharmacotherapy Prostate Risk factors storage symptoms transurethral resection of the prostate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!